Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
Emerging evidence has demonstrated that epigenetic regulation plays a vital role in gene expression under normal and pathological conditions. Alterations in the expression and activation of histone methyltransferases (HMTs) have been reported in preclinical models of multiple kidney diseases, includ...
Main Authors: | Chao Yu, Shougang Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01393/full |
Similar Items
-
Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
by: Tingting Li, et al.
Published: (2021-02-01) -
The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
by: Xun Zhou, et al.
Published: (2022-04-01) -
Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma
by: Virginia López, et al.
Published: (2021-08-01) -
The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
by: Xun Zhou, et al.
Published: (2021-06-01) -
Epigenetic Regulation of Host Defense Peptide Synthesis: Synergy Between Histone Deacetylase Inhibitors and DNA/Histone Methyltransferase Inhibitors
by: Melanie A. Whitmore, et al.
Published: (2022-04-01)